Advocacy Alert

The Centers for Medicare and Medicaid Services (CMS) recently proposed a National Coverage Determination that would exclude people with Down syndrome from taking part in clinical trials for an Alzheimer’s drug, and possibly deny them coverage for this drug. GLOBAL believes the CMS’ proposed determination must not stand.

 

Down Syndrome Association of Greater Richmond
1504 Santa Rosa Road, Suite 124  | Richmond, Virginia 23229
804-447-4713 | Info@dsagr.org

Follow Us

Having trouble viewing this email? View it in your web browser

Unsubscribe or Manage Your Preferences